BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Verran D, Kusyk T, Painter D, Fisher J, Koorey D, Strasser S, Stewart G, McCaughan G. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl. 2003;9:500-505. [PMID: 12740794 DOI: 10.1053/jlts.2003.50099] [Cited by in Crossref: 201] [Cited by in F6Publishing: 175] [Article Influence: 10.6] [Reference Citation Analysis]
Number Citing Articles
1 Busuttil R. Liver ischaemia and reperfusion injury. Br J Surg 2007;94:787-8. [PMID: 17571298 DOI: 10.1002/bjs.5921] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
2 Attia M, Silva MA, Mirza DF. The marginal liver donor--an update. Transpl Int. 2008;21:713-724. [PMID: 18492121 DOI: 10.1111/j.1432-2277.2008.00696.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 5.6] [Reference Citation Analysis]
3 Cesaretti M, Addeo P, Schiavo L, Anty R, Iannelli A. Assessment of Liver Graft Steatosis: Where Do We Stand? Liver Transpl. 2019;25:500-509. [PMID: 30380197 DOI: 10.1002/lt.25379] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
4 Feng S. Steatotic livers for liver transplantation—life-saving but at a cost. Nat Rev Gastroenterol Hepatol 2008;5:360-1. [DOI: 10.1038/ncpgasthep1159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
5 McCormack L, Dutkowski P, El-Badry AM, Clavien PA. Liver transplantation using fatty livers: always feasible? J Hepatol. 2011;54:1055-1062. [PMID: 21145846 DOI: 10.1016/j.jhep.2010.11.004] [Cited by in Crossref: 168] [Cited by in F6Publishing: 156] [Article Influence: 14.0] [Reference Citation Analysis]
6 Verran D, Dilworth P, Tang P, Mccaughan G. Use of Severely Steatotic Grafts in Liver Transplantation. Annals of Surgery 2008;248:142-3. [DOI: 10.1097/sla.0b013e31817cfd2b] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
7 Franzén LE, Ekstedt M, Kechagias S, Bodin L. Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting. Mod Pathol. 2005;18:912-916. [PMID: 15920560 DOI: 10.1038/modpathol.3800370] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 4.8] [Reference Citation Analysis]
8 Fondevila C, Jiménez-Galanes S, García-Valdecasas JC. [How can the number of liver transplantations be increased?]. Gastroenterol Hepatol 2009;32:519-30. [PMID: 19608299 DOI: 10.1016/j.gastrohep.2009.01.184] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
9 Deoliveira ML, Mccormack L, Clavien P. Clinical and experimental aspects of preservation injury in liver grafts: . Current Opinion in Organ Transplantation 2006;11:213-8. [DOI: 10.1097/01.mot.0000227835.98957.65] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Jadlowiec C, Smith M, Neville M, Mao S, Abdelwahab D, Reddy K, Moss A, Aqel B, Taner T. Acute Kidney Injury Patterns Following Transplantation of Steatotic Liver Allografts. J Clin Med 2020;9:E954. [PMID: 32235545 DOI: 10.3390/jcm9040954] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Frongillo F, Avolio AW, Nure E, Mulè A, Pepe G, Magalini SC, Agnes S. Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival. Transplant Proc 2009;41:1268-72. [PMID: 19460535 DOI: 10.1016/j.transproceed.2009.03.096] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
12 Spitzer AL, Lao OB, Dick AA, Bakthavatsalam R, Halldorson JB, Yeh MM, Upton MP, Reyes JD, Perkins JD. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl. 2010;16:874-884. [PMID: 20583086 DOI: 10.1002/lt.22085] [Cited by in Crossref: 211] [Cited by in F6Publishing: 187] [Article Influence: 17.6] [Reference Citation Analysis]
13 Randall HB, Klintmalm GB. Postoperative Intensive Care Unit Management: Adult Liver Transplant Recipients. Transplantation of the Liver. Elsevier; 2005. pp. 833-51. [DOI: 10.1016/b978-0-7216-0118-2.50061-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Segev DL, Maley WR, Simpkins CE, Locke JE, Nguyen GC, Montgomery RA, Thuluvath PJ. Minimizing risk associated with elderly liver donors by matching to preferred recipients. Hepatology. 2007;46:1907-1918. [PMID: 17918247 DOI: 10.1002/hep.21888] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 5.0] [Reference Citation Analysis]
15 Anderson CD, Upadhya G, Conzen KD, Jia J, Brunt EM, Tiriveedhi V, Xie Y, Ramachandran S, Mohanakumar T, Davidson NO, Chapman WC. Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts. Liver Transpl 2011;17:189-200. [PMID: 21280192 DOI: 10.1002/lt.22220] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
16 Fan L, Fu Z, Xiong Y, Ye S, Wang Y, Peng G, Ye Q. Double-lobectomy in a steatotic liver transplantation rat model. Exp Ther Med 2021;21:256. [PMID: 33603863 DOI: 10.3892/etm.2021.9687] [Reference Citation Analysis]
17 Orman ES, Mayorga ME, Wheeler SB, Townsley RM, Toro-Diaz HH, Hayashi PH, Barritt AS 4th. Declining liver graft quality threatens the future of liver transplantation in the United States. Liver Transpl. 2015;21:1040-1050. [PMID: 25939487 DOI: 10.1002/lt.24160] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 9.7] [Reference Citation Analysis]
18 Bloom MB, Raza S, Bhakta A, Ewing T, Patel M, Ley EJ, Margulies DR, Salim A, Malinoski D. Impact of deceased organ donor demographics and critical care end points on liver transplantation and graft survival rates. J Am Coll Surg 2015;220:38-47. [PMID: 25458800 DOI: 10.1016/j.jamcollsurg.2014.09.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
19 Rajaram RB, Jayaraman T, Yoong BK, Koh PS, Loh PS, Koong JK, Khalil AA, Md Hashim NH, Jamaluddin FH, Mahadeva S. Non-alcoholic fatty liver disease and obesity among adult donors are major challenges to living donor liver transplantation: A single-centre experience. Asian J Surg 2021:S1015-9584(21)00462-0. [PMID: 34384674 DOI: 10.1016/j.asjsur.2021.07.046] [Reference Citation Analysis]
20 Bessems M, Doorschodt BM, Kolkert JL, Vetelainen RL, van Vliet AK, Vreeling H, van Marle J, van Gulik TM. Preservation of steatotic livers: a comparison between cold storage and machine perfusion preservation. Liver Transpl. 2007;13:497-504. [PMID: 17394146 DOI: 10.1002/lt.21039] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 4.8] [Reference Citation Analysis]
21 Saab S, Kardashian A, Saggi S, Choi G, Agopian V, Tong MJ. Use of hepatitis C-positive grafts in hepatitis C-negative liver transplant recipients is cost effective. Clin Transplant 2018;32:e13383. [PMID: 30129981 DOI: 10.1111/ctr.13383] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
22 Silberhumer GR, Rahmel A, Karam V, Gonen M, Gyoeri G, Kern B, Adam R, Muehlbacher F, Rogiers X, Burroughs AK, Berlakovich GA. The difficulty in defining extended donor criteria for liver grafts: the Eurotransplant experience. Transpl Int. 2013;26:990-998. [PMID: 23931659 DOI: 10.1111/tri.12156] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
23 Carbone M, Lerut J, Neuberger J. How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology? World J Gastroenterol 2012; 18(47): 6908-6917 [PMID: 23322988 DOI: 10.3748/wjg.v18.i47.6908] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Jiménez-Castro MB, Gracia-Sancho J, Peralta C. Brain death and marginal grafts in liver transplantation. Cell Death Dis 2015;6:e1777. [PMID: 26043077 DOI: 10.1038/cddis.2015.147] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
25 Nagai K, Yagi S, Afify M, Bleilevens C, Uemoto S, Tolba RH. Impact of venous-systemic oxygen persufflation with nitric oxide gas on steatotic grafts after partial orthotopic liver transplantation in rats. Transplantation. 2013;95:78-84. [PMID: 23263502 DOI: 10.1097/tp.0b013e318277e2d1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
26 Joe E, Lee JM, Kim KW, Lee KB, Kim SJ, Baek JH, Shin CI, Suh KS, Yi NJ, Han JK, Choi BI. Quantification of hepatic macrosteatosis in living, related liver donors using T1-independent, T2*-corrected chemical shift MRI. J Magn Reson Imaging 2012;36:1124-30. [PMID: 22761083 DOI: 10.1002/jmri.23738] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
27 Bejaoui M, Pantazi E, De Luca V, Panisello A, Folch-Puy E, Hotter G, Capasso C, T Supuran C, Roselló-Catafau J. Carbonic Anhydrase Protects Fatty Liver Grafts against Ischemic Reperfusion Damage. PLoS One 2015;10:e0134499. [PMID: 26225852 DOI: 10.1371/journal.pone.0134499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
28 Landaverde C, Berenguer M, Aguilera V, San Juan F, Prieto M, Berenguer J. Retrasplante hepático: análisis de los resultados en 50 pacientes. Medicina Clínica 2005;124:721-5. [DOI: 10.1157/13075442] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
29 Dimou FM, Mehta HB, Adhikari D, Harland RC, Riall TS, Kuo YF. The role of extended criteria donors in liver transplantation for nonalcoholic steatohepatitis. Surgery 2016;160:1533-43. [PMID: 27554622 DOI: 10.1016/j.surg.2016.06.051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
30 Prakoso E, Verran D, Dilworth P, Kyd G, Tang P, Tse C, Koorey DJ, Strasser SI, Stormon M, Shun A, Thomas G, Joseph D, Pleass H, Gallagher J, Allen R, Crawford M, McCaughan GW, Shackel NA. Increasing liver transplantation waiting list mortality: a report from the Australian National Liver Transplantation Unit, Sydney. Intern Med J 2010;40:619-25. [PMID: 20840212 DOI: 10.1111/j.1445-5994.2010.02277.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
31 Savas N, Coskun M, Bilezikci B, Uruc I, Karakayali H, Yilmaz U, Haberal M. Value of an individual liver biopsy in the preoperative evaluation of apparently healthy potential liver donors. Liver Transpl 2008;14:541-6. [DOI: 10.1002/lt.21410] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
32 Zhang QY, Zhang QF, Zhang DZ. The Impact of Steatosis on the Outcome of Liver Transplantation: A Meta-Analysis. Biomed Res Int 2019;2019:3962785. [PMID: 31218224 DOI: 10.1155/2019/3962785] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
33 Kato H, Duarte S, Miller MG, Busuttil RW, Coito AJ. Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice. Liver Transpl 2019;25:288-301. [PMID: 30358115 DOI: 10.1002/lt.25365] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Deroose JP, Kazemier G, Zondervan P, Ijzermans JN, Metselaar HJ, Alwayn IP. Hepatic steatosis is not always a contraindication for cadaveric liver transplantation. HPB (Oxford). 2011;13:417-425. [PMID: 21609375 DOI: 10.1111/j.1477-2574.2011.00310.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
35 Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Cillo U, Zanus G, Fagiuoli S, Rugge M. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Liver Transpl. 2009;15:619-628. [PMID: 19479805 DOI: 10.1002/lt.21761] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
36 Frühauf NR, Fischer-fröhlich C, Kutschmann M, Schmidtmann I, Kirste G. Joint Impact of Donor and Recipient Parameters on the Outcome of Liver Transplantation in Germany. Transplantation 2011;92:1378-84. [DOI: 10.1097/tp.0b013e318236cd2f] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
37 Núñez KG, Frank A, Gonzalez-Rosario J, Galliano G, Bridle K, Crawford D, Seal J, Abbruscato F, Vashistha H, Thevenot PT, Cohen AJ. Interleukin-33 / Cyclin D1 imbalance in severe liver steatosis predicts susceptibility to ischemia reperfusion injury. PLoS One 2019;14:e0216242. [PMID: 31034519 DOI: 10.1371/journal.pone.0216242] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Koehler E, Watt K, Charlton M. Fatty Liver and Liver Transplantation. Clinics in Liver Disease 2009;13:621-30. [DOI: 10.1016/j.cld.2009.07.010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
39 Cheng Q, Ng KT, Fan ST, Lim ZX, Guo DY, Liu XB, Liu Y, Poon RT, Lo CM, Man K. Distinct mechanism of small-for-size fatty liver graft injury--Wnt4 signaling activates hepatic stellate cells. Am J Transplant 2010;10:1178-88. [PMID: 20420630 DOI: 10.1111/j.1600-6143.2010.03102.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
40 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol. 2016;64:433-485. [PMID: 26597456 DOI: 10.1016/j.jhep.2015.10.006] [Cited by in Crossref: 390] [Cited by in F6Publishing: 292] [Article Influence: 55.7] [Reference Citation Analysis]
41 Gordon Burroughs S, Busuttil RW. Optimal utilization of extended hepatic grafts. Surg Today. 2009;39:746-751. [PMID: 19779769 DOI: 10.1007/s00595-008-4022-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
42 Adani G, Baccarani U, Sainz-barriga M, Lorenzin D, Bresadola V, Risaliti A, Avellini C, Trevisan G, De Candia A, Bresadola F. The Role of Hepatic Biopsy to Detect Macrovacuolar Steatosis During Liver Procurement. Transplantation Proceedings 2006;38:1404-6. [DOI: 10.1016/j.transproceed.2006.02.111] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
43 Lee JY, Kim KM, Lee SG, Yu E, Lim Y, Lee HC, Chung Y, Lee YS, Suh D. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: A review of 589 consecutive liver biopsies in a single center. Journal of Hepatology 2007;47:239-44. [DOI: 10.1016/j.jhep.2007.02.007] [Cited by in Crossref: 176] [Cited by in F6Publishing: 159] [Article Influence: 11.7] [Reference Citation Analysis]
44 Merion RM, Goodrich NP, Feng S. How can we define expanded criteria for liver donors? J Hepatol. 2006;45:484-488. [PMID: 16905221 DOI: 10.1016/j.jhep.2006.07.016] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 4.2] [Reference Citation Analysis]
45 Jiménez-Castro MB, Cornide-Petronio ME, Gracia-Sancho J, Casillas-Ramírez A, Peralta C. Mitogen Activated Protein Kinases in Steatotic and Non-Steatotic Livers Submitted to Ischemia-Reperfusion. Int J Mol Sci 2019;20:E1785. [PMID: 30974915 DOI: 10.3390/ijms20071785] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
46 Baidya R, Crawford DHG, Gautheron J, Wang H, Bridle KR. Necroptosis in Hepatosteatotic Ischaemia-Reperfusion Injury. Int J Mol Sci 2020;21:E5931. [PMID: 32824744 DOI: 10.3390/ijms21165931] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
47 von Heesen M, Seibert K, Hülser M, Scheuer C, Wagner M, Menger MD, Schilling MK, Moussavian MR. Multidrug donor preconditioning protects steatotic liver grafts against ischemia-reperfusion injury. Am J Surg. 2012;203:168-176. [PMID: 21782153 DOI: 10.1016/j.amjsurg.2011.01.026] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
48 Beijert I, Mert S, Huang V, Karimian N, Geerts S, Hafiz EOA, Markmann JF, Yeh H, Porte RJ, Uygun K. Endothelial Dysfunction in Steatotic Human Donor Livers: A Pilot Study of the Underlying Mechanism During Subnormothermic Machine Perfusion. Transplant Direct 2018;4:e345. [PMID: 29796416 DOI: 10.1097/TXD.0000000000000779] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
49 Pamecha V, Borle DP, Kumar S, Bharathy KGS, Sinha PK, Sasturkar SV, Sharma V, Pandey CK, Sarin SK. Deceased donor liver transplant: Experience from a public sector hospital in India. Indian J Gastroenterol 2018;37:18-24. [DOI: 10.1007/s12664-017-0801-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
50 Corradini SG, Elisei W, De Marco R, Siciliano M, Iappelli M, Pugliese F, Ruberto F, Nudo F, Pretagostini R, Bussotti A, Mennini G, Eramo A, Liguori F, Merli M, Attili AF, Muda AO, Natalizi S, Berloco P, Rossi M. Preharvest donor hyperoxia predicts good early graft function and longer graft survival after liver transplantation. Liver Transpl 2005;11:140-51. [DOI: 10.1002/lt.20339] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
51 Xia W, Ke Q, Wang Y, Feng X, Guo H, Wang W, Zhang M, Shen Y, Wu J, Xu X, Yan S, Zheng S. Donation after cardiac death liver transplantation: Graft quality evaluation based on pretransplant liver biopsy. Liver Transpl 2015;21:838-46. [PMID: 25824672 DOI: 10.1002/lt.24123] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
52 de Oliveira GR, Sankarankutty AK, Castro e Silva O, Ferreira J, Kurachi C, Zucoloto S, Vannucchi H, Jordão AA, Marchini JS, Bagnato VS. Fluorescence spectroscopy to diagnose hepatic steatosis in a rat model of fatty liver. Liver International 2009;29:331-6. [DOI: 10.1111/j.1478-3231.2008.01878.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
53 Clavien PA, Oberkofler CE, Raptis DA, Lehmann K, Rickenbacher A, El-Badry AM. What is critical for liver surgery and partial liver transplantation: size or quality? Hepatology. 2010;52:715-729. [PMID: 20683967 DOI: 10.1002/hep.23713] [Cited by in Crossref: 77] [Cited by in F6Publishing: 62] [Article Influence: 6.4] [Reference Citation Analysis]
54 Croome KP, Lee DD, Taner CB. The “Skinny” on Assessment and Utilization of Steatotic Liver Grafts: A Systematic Review: Liver Transplantation. Liver Transpl 2019;25:488-99. [DOI: 10.1002/lt.25408] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
55 Gabrielli M, Moisan F, Vidal M, Duarte I, Jiménez M, Izquierdo G, Domínguez P, Méndez J, Soza A, Benitez C, Pérez R, Arrese M, Guerra J, Jarufe N, Martínez J. Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study. Annals of Hepatology 2012;11:891-8. [DOI: 10.1016/s1665-2681(19)31415-2] [Cited by in Crossref: 37] [Article Influence: 3.7] [Reference Citation Analysis]
56 Jiménez-Romero C, Caso Maestro O, Cambra Molero F, Justo Alonso I, Alegre Torrado C, Manrique Municio A, Calvo Pulido J, Loinaz Segurola C, Moreno González E. Using old liver grafts for liver transplantation: Where are the limits? World J Gastroenterol 2014; 20(31): 10691-10702 [PMID: 25152573 DOI: 10.3748/wjg.v20.i31.10691] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 49] [Article Influence: 7.1] [Reference Citation Analysis]
57 Mancia C, Loustaud-Ratti V, Carrier P, Naudet F, Bellissant E, Labrousse F, Pichon N. Controlled Attenuation Parameter and Liver Stiffness Measurements for Steatosis Assessment in the Liver Transplant of Brain Dead Donors. Transplantation. 2015;99:1619-1624. [PMID: 25719261 DOI: 10.1097/tp.0000000000000652] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
58 McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg. 2007;246:940-946; discussion 946-948. [PMID: 18043095 DOI: 10.1097/sla.0b013e31815c2a3f] [Cited by in Crossref: 182] [Cited by in F6Publishing: 47] [Article Influence: 13.0] [Reference Citation Analysis]
59 Hałoń A, Patrzałek D, Rabczyński J. Hepatic Steatosis in Liver Transplant Donors: Rare Phenomenon or Common Feature of Donor Population? Transplantation Proceedings 2006;38:193-5. [DOI: 10.1016/j.transproceed.2005.11.088] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
60 McLaughlin BL, Wells AC, Virtue S, Vidal-Puig A, Wilkinson TD, Watson CJ, Robertson PA. Electrical and optical spectroscopy for quantitative screening of hepatic steatosis in donor livers. Phys Med Biol 2010;55:6867-79. [PMID: 21048293 DOI: 10.1088/0031-9155/55/22/017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
61 Croome KP, Lee DD, Croome S, Chadha R, Livingston D, Abader P, Keaveny AP, Taner CB. The impact of postreperfusion syndrome during liver transplantation using livers with significant macrosteatosis. Am J Transplant 2019;19:2550-9. [DOI: 10.1111/ajt.15330] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
62 Abudhaise H, Luong TV, Watkins J, Fuller BJ, Davidson BR. Reliability and Accuracy of Clinical Assessment and Digital Image Analysis for Steatosis Evaluation in Discarded Human Livers. Transplantation Proceedings 2019;51:1679-83. [DOI: 10.1016/j.transproceed.2019.04.054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
63 Hu C, Zhao L, Zhang F, Li L. Regulation of autophagy protects against liver injury in liver surgery-induced ischaemia/reperfusion. J Cell Mol Med 2021;25:9905-17. [PMID: 34626066 DOI: 10.1111/jcmm.16943] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Liu Z, Gong J, Yan L. Quantitative estimation of the degree of hepatic macrovesicular steatosis in a disease-free population: A single-center experience in mainland China: Hepatic Macrovesicular Steatosis. Liver Transpl 2009;15:1605-12. [DOI: 10.1002/lt.21812] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
65 Bessems M, Doorschodt BM, van Marle J, Vreeling H, Meijer AJ, van Gulik TM. Improved machine perfusion preservation of the non-heart-beating donor rat liver using Polysol: a new machine perfusion preservation solution. Liver Transpl. 2005;11:1379-1388. [PMID: 16237689 DOI: 10.1002/lt.20502] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
66 Durand F, Renz JF, Alkofer B, Burra P, Clavien PA, Porte RJ, Freeman RB, Belghiti J. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl. 2008;14:1694-1707. [PMID: 19025925 DOI: 10.1002/lt.21668] [Cited by in Crossref: 205] [Cited by in F6Publishing: 163] [Article Influence: 15.8] [Reference Citation Analysis]
67 Dasari BVM, Schlegel A, Mergental H, Perera MTPR. The use of old donors in liver transplantation. Best Pract Res Clin Gastroenterol. 2017;31:211-217. [PMID: 28624109 DOI: 10.1016/j.bpg.2017.03.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
68 Chu MJ, Vather R, Hickey AJ, Phillips AR, Bartlett AS. Impact of ischemic preconditioning on outcome in clinical liver surgery: a systematic review. Biomed Res Int 2015;2015:370451. [PMID: 25756045 DOI: 10.1155/2015/370451] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
69 Geenen ILA, Sosef MN, Shun A, Crawford M, Gallagher J, Strasser S, Stormon M, Mccaughan G, Verran DJ. Usage and outcomes of deceased donor liver allografts with preprocurement injury from blunt trauma: Preprocurement Injury from Blunt Trauma. Liver Transpl 2009;15:321-5. [DOI: 10.1002/lt.21687] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
70 Cameron A, Busuttil RW. AASLD/ILTS transplant course: Is there an extended donor suitable for everyone? Liver Transpl 2005;11:S2-5. [DOI: 10.1002/lt.20596] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
71 Matsuda A, Kuriyama N, Kato H, Tanemura A, Murata Y, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S. Comparative Study on the Cytoprotective Effects of Activated Protein C Treatment in Nonsteatotic and Steatotic Livers under Ischemia-Reperfusion Injury. Biomed Res Int 2015;2015:635041. [PMID: 26539519 DOI: 10.1155/2015/635041] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
72 Azabdaftari G, Pomfret EA, Simpson MA, Pomposelli JJ, David Lewis W, Jenkins RL, Gordon FD, Khettry U. Excellent outcome following transplantation of a domino donor liver with high-grade macrosteatosis. Pathology - Research and Practice 2004;200:581-7. [DOI: 10.1016/j.prp.2004.06.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
73 Wigg AJ, Gunson BK, Mutimer DJ. Outcomes following liver transplantation for seronegative acute liver failure: experience during a 12-year period with more than 100 patients. Liver Transpl. 2005;11:27-34. [PMID: 15690533 DOI: 10.1002/lt.20289] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 3.8] [Reference Citation Analysis]
74 Cursio R, Colosetti P, Gugenheim J. Autophagy and liver ischemia-reperfusion injury. Biomed Res Int. 2015;2015:417590. [PMID: 25861623 DOI: 10.1155/2015/417590] [Cited by in Crossref: 59] [Cited by in F6Publishing: 67] [Article Influence: 8.4] [Reference Citation Analysis]
75 van der Graaff D, Kwanten WJ, Francque SM. The potential role of vascular alterations and subsequent impaired liver blood flow and hepatic hypoxia in the pathophysiology of non-alcoholic steatohepatitis. Med Hypotheses 2019;122:188-97. [PMID: 30593409 DOI: 10.1016/j.mehy.2018.11.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
76 Ayloo S, Molinari M, Pentakota SR. Combined Effect of Deceased Donor Macrovesicular and Microvesicular Steatosis on Liver Transplantation Outcomes: Analysis of SRTR Data Between 2010 and 2018. Transplant Proc 2021:S0041-1345(21)00693-X. [PMID: 34740448 DOI: 10.1016/j.transproceed.2021.08.046] [Reference Citation Analysis]
77 Angulo P. Nonalcoholic fatty liver disease and liver transplantation. Liver Transpl. 2006;12:523-534. [PMID: 16555318 DOI: 10.1002/lt.20738] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 6.5] [Reference Citation Analysis]
78 Farrell GC, Teoh NC, McCuskey RS. Hepatic microcirculation in fatty liver disease. Anat Rec (Hoboken). 2008;291:684-692. [PMID: 18484615 DOI: 10.1002/ar.20715] [Cited by in Crossref: 166] [Cited by in F6Publishing: 159] [Article Influence: 11.9] [Reference Citation Analysis]
79 Westerkamp AC, de Boer MT, van den Berg AP, Gouw AS, Porte RJ. Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short. Transpl Int. 2015;28:319-329. [PMID: 25545740 DOI: 10.1111/tri.12504] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
80 Grazi G, Ravaioli M, Zanello M, Ercolani G, Cescon M, Varotti G, Del Gaudio M, Vetrone G, Lauro A, Ramacciato G, Pinna A. Using Elderly Donors in Liver Transplantation. Transplantation Proceedings 2005;37:2582-3. [DOI: 10.1016/j.transproceed.2005.06.056] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
81 Sass DA, Reich DJ. Liver transplantation in the 21st century: expanding the donor options. Gastroenterol Clin North Am. 2011;40:641-658. [PMID: 21893278 DOI: 10.1016/j.gtc.2011.06.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
82 Zimmerman MA, Martin A, Hong JC. Basic considerations in organ perfusion physiology: . Current Opinion in Organ Transplantation 2016;21:288-93. [DOI: 10.1097/mot.0000000000000312] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Evers DJ, Westerkamp AC, Spliethoff JW, Pully VV, Hompes D, Hendriks BHW, Prevoo W, van Velthuysen MF, Porte RJ, Ruers TJM. Diffuse reflectance spectroscopy: toward real-time quantification of steatosis in liver. Transpl Int 2015;28:465-74. [DOI: 10.1111/tri.12517] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
84 Forbes SJ, Newsome PN. Liver regeneration - mechanisms and models to clinical application. Nat Rev Gastroenterol Hepatol. 2016;13:473-485. [PMID: 27353402 DOI: 10.1038/nrgastro.2016.97] [Cited by in Crossref: 152] [Cited by in F6Publishing: 138] [Article Influence: 25.3] [Reference Citation Analysis]
85 Zhang T, Dunson J, Kanwal F, Galvan NTN, Vierling JM, O'Mahony C, Goss JA, Rana A. Trends in Outcomes for Marginal Allografts in Liver Transplant. JAMA Surg 2020. [PMID: 32777009 DOI: 10.1001/jamasurg.2020.2484] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
86 Barbas AS, Goldaracena N, Dib MJ, Selzner M. Ex-vivo liver perfusion for organ preservation: Recent advances in the field. Transplant Rev (Orlando) 2016;30:154-60. [PMID: 27158081 DOI: 10.1016/j.trre.2016.03.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
87 Rogier J, Roullet S, Cornélis F, Biais M, Quinart A, Revel P, Bioulac-Sage P, Le Bail B. Noninvasive assessment of macrovesicular liver steatosis in cadaveric donors based on computed tomography liver-to-spleen attenuation ratio. Liver Transpl 2015;21:690-5. [PMID: 25761371 DOI: 10.1002/lt.24105] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
88 Liu Z, Jia J, Ning H, Que S, Zhou L, Zheng S. Systematic Evaluation of the Safety Threshold for Allograft Macrovesicular Steatosis in Cadaveric Liver Transplantation. Front Physiol 2019;10:429. [PMID: 31105577 DOI: 10.3389/fphys.2019.00429] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
89 Schemmer P, Nickkholgh A, Gerling T, Weitz J, Büchler MW, Schmidt J. Rescue allocation for liver transplantation within Eurotransplant: the Heidelberg experience: Rescue allocation in liver transplantation. Clinical Transplantation 2009;23:42-8. [DOI: 10.1111/j.1399-0012.2009.01109.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
90 Mccormack L, Clavien P. Understanding the meaning of fat in the liver. Liver Transpl 2005;11:137-9. [DOI: 10.1002/lt.20354] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
91 Liss KHH, Ek SE, Lutkewitte AJ, Pietka TA, He M, Skaria P, Tycksen E, Ferguson D, Blanc V, Graham MJ, Hall AM, McGill MR, McCommis KS, Finck BN. Monoacylglycerol Acyltransferase 1 Knockdown Exacerbates Hepatic Ischemia/Reperfusion Injury in Mice With Hepatic Steatosis. Liver Transpl 2021;27:116-33. [PMID: 32916011 DOI: 10.1002/lt.25886] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Karimian N, Yeh H. Opportunities for Therapeutic Intervention During Machine Perfusion. Curr Transplant Rep 2017;4:141-8. [PMID: 29109929 DOI: 10.1007/s40472-017-0144-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
93 Wu C, Lu C, Xu C. Short-term and long-term outcomes of liver transplantation using moderately and severely steatotic donor livers: A systematic review. Medicine (Baltimore) 2018;97:e12026. [PMID: 30170411 DOI: 10.1097/MD.0000000000012026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
94 Halazun KJ, Quillin RC, Rosenblatt R, Bongu A, Griesemer AD, Kato T, Smith C, Michelassi F, Guarrera JV, Samstein B, Brown RS, Emond JC. Expanding the Margins: High Volume Utilization of Marginal Liver Grafts Among >2000 Liver Transplants at a Single Institution. Annals of Surgery 2017;266:441-9. [DOI: 10.1097/sla.0000000000002383] [Cited by in Crossref: 30] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
95 Berenguer M. Risk of extended criteria donors in hepatitis C virus-positive recipients. Liver Transpl. 2008;14 Suppl 2:S45-S50. [PMID: 18825715 DOI: 10.1002/lt.21617] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
96 Kumar R. Hard clinical outcomes in patients with NAFLD. Hepatol Int 2013;7 Suppl 2:790-9. [PMID: 26202293 DOI: 10.1007/s12072-013-9455-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
97 Andert A, Ulmer TF, Schöning W, Kroy D, Hein M, Alizai PH, Heidenhain C, Neumann U, Schmeding M. Grade of donor liver microvesicular steatosis does not affect the postoperative outcome after liver transplantation. Hepatobiliary & Pancreatic Diseases International 2017;16:617-23. [DOI: 10.1016/s1499-3872(17)60064-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 3.6] [Reference Citation Analysis]
98 Kato H, Kuriyama N, Duarte S, Clavien PA, Busuttil RW, Coito AJ. MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury. J Hepatol 2014;60:1032-9. [PMID: 24412604 DOI: 10.1016/j.jhep.2013.12.022] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
99 Thomsen KL, Robertson FP, Holland-Fischer P, Davidson BR, Mookerjee RP, Møller HJ, Jalan R, Grønbæk H. The Macrophage Activation Marker Soluble CD163 is Associated With Early Allograft Dysfunction After Liver Transplantation. J Clin Exp Hepatol 2019;9:302-11. [PMID: 31360022 DOI: 10.1016/j.jceh.2018.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
100 Stoll P, Schwer CI, Goebel U, Buerkle H, Hoetzel A, Schmidt R. Hepatic steatosis prevents heme oxygenase-1 induction by isoflurane in the rat liver. World J Gastroenterol 2011; 17(37): 4184-4190 [PMID: 22072849 DOI: 10.3748/wjg.v17.i37.4184] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
101 Xu C, Zhang X, Yu C, Lu G, Chen S, Xu L, Ding W, Shi Q, Li Y. Proteomic analysis of hepatic ischemia/reperfusion injury and ischemic preconditioning in mice revealed the protective role of ATP5β. Proteomics. 2009;9:409-419. [PMID: 19142948 DOI: 10.1002/pmic.200800393] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
102 Marsman H, Matsushita T, Dierkhising R, Kremers W, Rosen C, Burgart L, Nyberg SL. Assessment of donor liver steatosis: pathologist or automated software? Hum Pathol 2004;35:430-5. [PMID: 15116323 DOI: 10.1016/j.humpath.2003.10.029] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 3.6] [Reference Citation Analysis]
103 Jiménez-romero C, Clemares-lama M, Manrique-municio A, García-sesma A, Calvo-pulido J, Moreno-gonzález E. Long-Term Results Using Old Liver Grafts for Transplantation: Sexagenerian Versus Liver Donors Older than 70 Years. World J Surg 2013;37:2211-21. [DOI: 10.1007/s00268-013-2085-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
104 Shin Y, Ko J, Kim G, Gwak M, Sim W, Ryu J, Kim J, Kwon C, Joh J. The Effects of Intermittent Inflow Occlusion and Hepatic Steatosis on Postoperative Liver Functions in Living Liver Donors Undergoing Right Hepatectomy. Transplantation Proceedings 2012;44:380-3. [DOI: 10.1016/j.transproceed.2012.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
105 Jakubauskiene L, Jakubauskas M, Stiegler P, Leber B, Schemmer P, Strupas K. Ischemic Preconditioning for Liver Transplantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Visc Med 2021;37:329-37. [PMID: 34722716 DOI: 10.1159/000516608] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Tevar AD, Clarke C, Wang J, Rudich SM, Woodle ES, Lentsch AB, Edwards ML. Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation. J Am Coll Surg. 2010;210:515-526. [PMID: 20347746 DOI: 10.1016/j.jamcollsurg.2010.01.020] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
107 Zhu H, Zhang Q, Chen G. CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease. Int Immunopharmacol 2019;72:224-34. [PMID: 31002999 DOI: 10.1016/j.intimp.2019.04.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
108 Yang HT, Chen KF, Lu Q, Wei YG, Li B, Qin Y, Huang WQ. Ultrasonic integrated backscatter in assessing liver steatosis before and after liver transplantation. Hepatobiliary Pancreat Dis Int 2014;13:402-8. [PMID: 25100125 DOI: 10.1016/s1499-3872(14)60039-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
109 Bangru S, Kalsotra A. Cellular and molecular basis of liver regeneration. Semin Cell Dev Biol 2020;100:74-87. [PMID: 31980376 DOI: 10.1016/j.semcdb.2019.12.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
110 Ydreborg M, Westin J, Lagging M, Castedal M, Friman S. Impact of donor histology on survival following liver transplantation for chronic hepatitis C virus infection: a Scandinavian single-center experience. Scand J Gastroenterol. 2012;47:710-717. [PMID: 22452366 DOI: 10.3109/00365521.2012.672592] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
111 de Rougemont O, Lehmann K, Clavien PA. Preconditioning, organ preservation, and postconditioning to prevent ischemia-reperfusion injury to the liver. Liver Transpl. 2009;15:1172-1182. [PMID: 19790166 DOI: 10.1002/lt.21876] [Cited by in Crossref: 92] [Cited by in F6Publishing: 89] [Article Influence: 7.1] [Reference Citation Analysis]
112 Williams R. Global challenges in liver disease. Hepatology 2006;44:521-6. [DOI: 10.1002/hep.21347] [Cited by in Crossref: 492] [Cited by in F6Publishing: 475] [Article Influence: 30.8] [Reference Citation Analysis]
113 Turgeon NA, Sollinger HW, Fernandez LA, Musat AI, Chin LT, Kalayoglu M, Knechtle SJ, D’alessandro AM. Hepatic steatosis and liver transplantation: . Current Opinion in Organ Transplantation 2004;9:123-9. [DOI: 10.1097/01.mot.0000127681.70265.bc] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
114 Gastaca M. Extended Criteria Donors in Liver Transplantation: Adapting Donor Quality and Recipient. Transplantation Proceedings 2009;41:975-9. [DOI: 10.1016/j.transproceed.2009.02.016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
115 Muscari F, Guinard JP, Foppa B, Trocard P, Danjoux M, Kamel MS, Duffas JP, Rostaing L, Fourtanier G, Suc B. Biological changes after liver transplantation according to the presence or not of graft steatosis. Transplant Proc 2008;40:3562-5. [PMID: 19100438 DOI: 10.1016/j.transproceed.2008.06.087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
116 Okamura Y, Hata K, Tanaka H, Hirao H, Kubota T, Inamoto O, Kageyama S, Tamaki I, Yermek N, Yoshikawa J, Uemoto S. Impact of Subnormothermic Machine Perfusion Preservation in Severely Steatotic Rat Livers: A Detailed Assessment in an Isolated Setting. Am J Transplant. 2017;17:1204-1215. [PMID: 27860296 DOI: 10.1111/ajt.14110] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
117 . Retraction: "Safety limitations of fatty liver transplantation can be extended to 40%: Experience of a single centre in China", by Yu Z., Yu S., Zhang L., Feng X., Zhang M., et al. Liver Int 2017;37:767. [PMID: 27589369 DOI: 10.1111/liv.13244] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
118 Boteon YL, Boteon APCS, Attard J, Mergental H, Mirza DF, Bhogal RH, Afford SC. Ex situ machine perfusion as a tool to recondition steatotic donor livers: Troublesome features of fatty livers and the role of defatting therapies. A systematic review. Am J Transplant. 2018;18:2384-2399. [PMID: 29947472 DOI: 10.1111/ajt.14992] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
119 Lin F, Zhen F, Yan X, Shaojun Y, Guizhu P, Yanfeng W, Qifa Y. Hypothermic oxygenated perfusion with defatting cocktail further improves steatotic liver grafts in a transplantation rat model. Artif Organs 2021;45:E304-16. [PMID: 33908066 DOI: 10.1111/aor.13976] [Reference Citation Analysis]
120 Subramanian V, Seetharam AB, Vachharajani N, Tiriveedhi V, Angaswamy N, Ramachandran S, Crippin JS, Shenoy S, Chapman WC, Mohanakumar T, Anderson CD. Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation. Transplantation 2011;92:1259-68. [PMID: 22011763 DOI: 10.1097/TP.0b013e318235a1ab] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
121 Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Togashi J, Ohki T, Yoshida H, Omata M, Makuuchi M. Noninvasive estimation of hepatic steatosis in living liver donors: usefulness of visceral fat area measurement. Transplantation. 2009;88:575-581. [PMID: 19696642 DOI: 10.1097/tp.0b013e3181b11c19] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
122 Sun L, Marsh JN, Matlock MK, Chen L, Gaut JP, Brunt EM, Swamidass SJ, Liu TC. Deep learning quantification of percent steatosis in donor liver biopsy frozen sections. EBioMedicine. 2020;60:103029. [PMID: 32980688 DOI: 10.1016/j.ebiom.2020.103029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
123 Li J, Liu B, Yan LN, Zuo YX, Li B, Zeng Y, Zhang SF, Li FG. Reversal of graft steatosis after liver transplantation: prospective study. Transplant Proc 2009;41:3560-3. [PMID: 19917344 DOI: 10.1016/j.transproceed.2009.06.222] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
124 Yen Y, Kuo F, Lin C, Chen C, Chang K, Tsai M, Hu T. Predicting Hepatic Steatosis in Living Liver Donors Via Controlled Attenuation Parameter. Transplantation Proceedings 2018;50:3533-8. [DOI: 10.1016/j.transproceed.2018.06.039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
125 Villa R, Fondevila C, Erill I, Guimer?? A, Bombuy E, G??mez-su??rez C, Sacrist??n JC, Garc??a-valdecasas JC. Real-Time Direct Measurement of Human Liver Allograft Temperature from Recovery to Transplantation: . Transplantation 2006;81:483-6. [DOI: 10.1097/01.tp.0000195903.12999.bc] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
126 Graham JA, Guarrera JV. "Resuscitation" of marginal liver allografts for transplantation with machine perfusion technology. J Hepatol. 2014;61:418-431. [PMID: 24768755 DOI: 10.1016/j.jhep.2014.04.019] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 8.1] [Reference Citation Analysis]
127 Biesterfeld S, Knapp J, Bittinger F, Götte H, Schramm M, Otto G. Frozen section diagnosis in donor liver biopsies: observer variation of semiquantitative and quantitative steatosis assessment. Virchows Arch 2012;461:177-83. [PMID: 22772768 DOI: 10.1007/s00428-012-1271-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
128 Ferraz-Neto BH, Zurstrassen MP, Hidalgo R, Fonseca LE, Motta TD, Pandullo FL, Rezende MB, Meira-Filho SP, Sá JR, Afonso RC. Donor liver dysfunction: application of a new scoring system to identify the marginal donor. Transplant Proc 2007;39:2516-8. [PMID: 17954162 DOI: 10.1016/j.transproceed.2007.07.034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
129 Hafez TS, Glantzounis GK, Fusai G, Taanman JW, Wignarajah P, Parkes H, Fuller B, Davidson BR, Seifalian AM. Intracellular oxygenation and cytochrome oxidase C activity in ischemic preconditioning of steatotic rabbit liver. Am J Surg. 2010;200:507-518. [PMID: 20409534 DOI: 10.1016/j.amjsurg.2009.09.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
130 Schuchmann S, Weigel C, Albrecht L, Kirsch M, Lemke A, Lorenz G, Warzok R, Hosten N. Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging. Eur J Radiol 2007;62:416-22. [PMID: 17267159 DOI: 10.1016/j.ejrad.2006.12.009] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 3.0] [Reference Citation Analysis]
131 McElroy LM, Daud A, Davis AE, Lapin B, Baker T, Abecassis MM, Levitsky J, Holl JL, Ladner DP. A meta-analysis of complications following deceased donor liver transplant. Am J Surg. 2014;208:605-618. [PMID: 25118164 DOI: 10.1016/j.amjsurg.2014.06.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
132 Carbone M, Lenci I, Baiocchi L. Prevention of hepatitis C recurrence after liver transplantation: An update. World J Gastrointest Pharmacol Ther 2012; 3(4): 36-48 [PMID: 22966482 DOI: 10.4292/wjgpt.v3.i4.36] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
133 Cameron AM, Ghobrial RM, Yersiz H, Farmer DG, Lipshutz GS, Gordon SA, Zimmerman M, Hong J, Collins TE, Gornbein J. Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg. 2006;243:748-753; discussion 753-755. [PMID: 16772778 DOI: 10.1097/01.sla.0000219669.84192.b3] [Cited by in Crossref: 207] [Cited by in F6Publishing: 171] [Article Influence: 12.9] [Reference Citation Analysis]
134 Rzaev RT, Kamalov IR, Tatarkina MA, Kryzhanovskaia EI, Semenkov AV, Kim SI, Khovrin VV, Sandrikov VA. [Transplantation of left lateral liver sector to child from mother with liver steatosis]. Khirurgiia (Mosk) 2015;:77-9. [PMID: 25909559 DOI: 10.17116/hirurgia2015177-79] [Reference Citation Analysis]
135 Khan RS, Newsome PN. Non-alcoholic fatty liver disease and liver transplantation. Metabolism. 2016;65:1208-1223. [PMID: 26997540 DOI: 10.1016/j.metabol.2016.02.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
136 Posner AD, Sultan ST, Zaghloul NA, Twaddell WS, Bruno DA, Hanish SI, Hutson WR, Hebert L, Barth RN, LaMattina JC. Resolution of donor non-alcoholic fatty liver disease following liver transplantation. Clin Transplant 2017;31. [PMID: 28636211 DOI: 10.1111/ctr.13032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
137 Hall AR, Dhillon AP, Green AC, Ferrell L, Crawford JM, Alves V, Balabaud C, Bhathal P, Bioulac-sage P, Guido M, Hytiroglou P, Nakanuma Y, Paradis V, Quaglia A, Snover D, Theise N, Thung S, Tsui W, van Leeuwen DJ. Hepatic steatosis estimated microscopically versus digital image analysis. Liver Int 2013;33:926-35. [DOI: 10.1111/liv.12162] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
138 Hata K, Tolba RH, Wei L, Doorschodt BM, Büttner R, Yamamoto Y, Minor T. Impact of polysol, a newly developed preservation solution, on cold storage of steatotic rat livers. Liver Transpl. 2007;13:114-121. [PMID: 17117434 DOI: 10.1002/lt.20957] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
139 Alvikas J, Deeb AP, Jorgensen DR, Minervini MI, Demetris AJ, Lemon K, Chen X, Labiner H, Malik S, Hughes C, Humar A, Tevar A. Moderately Macrosteatotic Livers Have Acceptable Long-Term Outcomes but Higher Risk of Immediate Mortality. Transplant Proc 2021;53:1682-9. [PMID: 33931249 DOI: 10.1016/j.transproceed.2021.03.024] [Reference Citation Analysis]
140 Baidya R, Gautheron J, Crawford DHG, Wang H, Bridle KR. Inhibition of MLKL Attenuates Necroptotic Cell Death in a Murine Cell Model of Ischaemia Injury. J Clin Med 2021;10:E212. [PMID: 33435617 DOI: 10.3390/jcm10020212] [Reference Citation Analysis]
141 Pratschke J, Mittler J, Neuhaus P. Ausweitung des Spenderpools unter Verwendung marginaler Organe. Chirurg 2008;79:130-4. [DOI: 10.1007/s00104-007-1458-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
142 Fujii T, Kuriyama N, Hayasaki A, Iizawa Y, Tanemura A, Kato H, Murata Y, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S. Recombinant Human Soluble Thrombomodulin Attenuates Hepatic Ischemia and/or Reperfusion Injury by Inhibiting Leukocyte Accumulation in Mice With Normal and Fatty Liver. Transplantation Proceedings 2018;50:2807-14. [DOI: 10.1016/j.transproceed.2018.03.044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
143 Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, Greenstein SM, Merion RM. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6:783-790. [PMID: 16539636 DOI: 10.1111/j.1600-6143.2006.01242.x] [Cited by in Crossref: 1279] [Cited by in F6Publishing: 1110] [Article Influence: 79.9] [Reference Citation Analysis]
144 Hashimoto K, Miller C. The use of marginal grafts in liver transplantation. J Hepatobiliary Pancreat Surg 2008;15:92-101. [DOI: 10.1007/s00534-007-1300-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
145 Steggerda JA, Kim IK, Malinoski D, Klein AS, Bloom MB. Regional Variation in Utilization and Outcomes of Liver Allografts From Donors With High Body Mass Index and Graft Macrosteatosis: A Role for Liver Biopsy. Transplantation 2019;103:122-30. [PMID: 30048394 DOI: 10.1097/TP.0000000000002379] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
146 Baker MA, Nandivada P, Mitchell PD, Fell GL, Pan A, Cho BS, De La Flor DJ, Anez-Bustillos L, Dao DT, Nosé V, Puder M. Omega-3 fatty acids are protective in hepatic ischemia reperfusion injury in the absence of GPR120 signaling. J Pediatr Surg 2019;54:2392-7. [PMID: 31036368 DOI: 10.1016/j.jpedsurg.2019.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
147 Noujaim HM, de Ville de Goyet J, Montero EF, Ribeiro CM, Capellozzi VL, Crescentini F, Casagrande M, Santos RG, Curvello L, de Miranda MP, Genzini T. Expanding Postmortem Donor Pool Using Steatotic Liver Grafts: A New Look. Transplantation 2009;87:919-25. [DOI: 10.1097/tp.0b013e31819b3f76] [Cited by in Crossref: 45] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
148 Bae C, Henry SD, Guarrera JV. Is extracorporeal hypothermic machine perfusion of the liver better than the ‘good old icebox’?: . Current Opinion in Organ Transplantation 2012;17:137-42. [DOI: 10.1097/mot.0b013e328351083d] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
149 Hübscher SG. Steatosis and fibrosis progression in patients with recurrent hepatitis C infection: Complex interactions providing diagnostic and therapeutic challenges. Liver Transpl 2011;17:1374-9. [DOI: 10.1002/lt.22452] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
150 Fonseca-neto OCLD, Miranda LEC, Sabat BD, Amorim AG, Adeodato L, Melo PSVD, Lopes HC, Lacerda CM, Pereira LMMB. O doador marginal: experiência de um centro de transplante de fígado. ABCD, arq bras cir dig 2008;21:1-5. [DOI: 10.1590/s0102-67202008000100001] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
151 Saggi BH, Farmer DG, Yersiz H, Busuttil RW. Surgical advances in liver and bowel transplantation. Anesthesiol Clin North Am 2004;22:713-40. [PMID: 15541932 DOI: 10.1016/j.atc.2004.07.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
152 D'Amico F, Vitale A, Gringeri E, Valmasoni M, Carraro A, Brolese A, Zanus G, Boccagni P, D'Amico DF, Cillo U. Liver transplantation using suboptimal grafts: impact of donor harvesting technique. Liver Transpl. 2007;13:1444-1450. [PMID: 17902131 DOI: 10.1002/lt.21268] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
153 Cucchetti A, Vivarelli M, Ravaioli M, Cescon M, Ercolani G, Piscaglia F, Del Gaudio M, Grazi GL, Ridolfi L, Pinna AD. Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? Clin Transplant. 2009;23:519-524. [PMID: 19486345 DOI: 10.1111/j.1399-0012.2009.00987.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
154 Fiorentino M, Vasuri F, Ravaioli M, Ridolfi L, Grigioni WF, Pinna AD, D'Errico-Grigioni A. Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation. Liver Transpl 2009;15:1821-5. [PMID: 19938115 DOI: 10.1002/lt.21948] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
155 Pratap A, Panakanti R, Yang N, Lakshmi R, Modanlou KA, Eason JD, Mahato RI. Cyclopamine attenuates acute warm ischemia reperfusion injury in cholestatic rat liver: hope for marginal livers. Mol Pharm 2011;8:958-68. [PMID: 21491930 DOI: 10.1021/mp200115v] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
156 Shin Y, Ko J, Kim G, Gwak M, Sim W, Lee A, Yi H, Joh J. Impact of Hepatic Macrovesicular and Microvesicular Steatosis on the Postoperative Liver Functions After Right Hepatectomy in Living Donors. Transplantation Proceedings 2012;44:512-5. [DOI: 10.1016/j.transproceed.2012.02.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
157 Chu MJ, Dare AJ, Phillips AR, Bartlett AS. Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review. J Gastrointest Surg. 2015;19:1713-1724. [PMID: 25917535 DOI: 10.1007/s11605-015-2832-1] [Cited by in Crossref: 81] [Cited by in F6Publishing: 80] [Article Influence: 11.6] [Reference Citation Analysis]
158 Nocito A, El-Badry AM, Clavien PA. When is steatosis too much for transplantation? J Hepatol. 2006;45:494-499. [PMID: 16919359 DOI: 10.1016/j.jhep.2006.07.017] [Cited by in Crossref: 114] [Cited by in F6Publishing: 109] [Article Influence: 7.1] [Reference Citation Analysis]
159 Liss KHH, McCommis KS, Chambers KT, Pietka TA, Schweitzer GG, Park SL, Nalbantoglu I, Weinheimer CJ, Hall AM, Finck BN. The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury. Liver Transpl. 2018;24:908-921. [PMID: 29729104 DOI: 10.1002/lt.25189] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
160 Dawwas MF, Gimson AE, Lewsey JD, Copley LP, van der Meulen JH. Survival after liver transplantation in the United Kingdom and Ireland compared with the United States. Gut. 2007;56:1606-1613. [PMID: 17356039 DOI: 10.1136/gut.2006.111369] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
161 Sandroussi C, Crawford M, Lockwood DS, Tang P, Gallagher JP, Pleass H, Strasser SI, Shackel NA, Mccaughan GW, Verran DJ. Donor and recipient selection leads to good patient and graft outcomes for right lobe split transplantation versus whole graft liver transplantation in adult recipients: Donor and Recipient Selection. Liver Transpl 2009;15:1586-93. [DOI: 10.1002/lt.21849] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
162 Lefkowitch JH. Hepatobiliary pathology. Curr Opin Gastroenterol 2004;20:188-97. [PMID: 15703643 DOI: 10.1097/00001574-200405000-00003] [Reference Citation Analysis]
163 Cornide-Petronio ME, Jiménez-Castro MB, Gracia-Sancho J, Peralta C. New Insights into the Liver-Visceral Adipose Axis During Hepatic Resection and Liver Transplantation. Cells 2019;8:E1100. [PMID: 31540413 DOI: 10.3390/cells8091100] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
164 Ciria R, Pleguezuelo M, Khorsandi SE, Davila D, Suddle A, Vilca-Melendez H, Rufian S, de la Mata M, Briceño J, Cillero PL, Heaton N. Strategies to reduce hepatitis C virus recurrence after liver transplantation. World J Hepatol 2013; 5(5): 237-250 [PMID: 23717735 DOI: 10.4254/wjh.v5.i5.237] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
165 Ferrigno A, Pasqua LGD, Bianchi A, Richelmi P, Vairetti M. Metabolic shift in liver: Correlation between perfusion temperature and hypoxia inducible factor-1α. World J Gastroenterol 2015; 21(4): 1108-1116 [PMID: 25632183 DOI: 10.3748/wjg.v21.i4.1108] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
166 Adalı G, Bozkurt B, Ceyhan Ö, Server S, Doğusoy GB, Yüzer Y, Tokat Y. Body Mass Index and Unenhanced CT as a Predictor of Hepatic Steatosis in Potential Liver Donors. Transplant Proc 2019;51:2373-8. [PMID: 31402250 DOI: 10.1016/j.transproceed.2019.02.047] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
167 Steggerda JA, Bloom MB, Noureddin M, Brennan TV, Todo T, Nissen NN, Klein AS, Kim IK. Higher thresholds for the utilization of steatotic allografts in liver transplantation: Analysis from a U.S. national database. PLoS One 2020;15:e0230995. [PMID: 32240235 DOI: 10.1371/journal.pone.0230995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
168 Quader M, Wolfe L, Katlaps G, Kasirajan V. Donor Heart Utilization following Cardiopulmonary Arrest and Resuscitation: Influence of Donor Characteristics and Wait Times in Transplant Regions. J Transplant 2014;2014:519401. [PMID: 25114798 DOI: 10.1155/2014/519401] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
169 Hessheimer AJ, Parramón D, Guimerà A, Erill I, Rimola A, García-valdecasas JC, Villa R, Fondevila C. A Rapid and Reliable Means of Assessing Hepatic Steatosis In Vivo Via Electrical Bioimpedance. Transplantation 2009;88:716-22. [DOI: 10.1097/tp.0b013e3181b391c0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
170 Goldaracena N, Cullen JM, Kim DS, Ekser B, Halazun KJ. Expanding the donor pool for liver transplantation with marginal donors. Int J Surg 2020;82S:30-5. [PMID: 32422385 DOI: 10.1016/j.ijsu.2020.05.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
171 Briceño J, Ciria R, Pleguezuelo M, de la Mata M, Muntané J, Naranjo A, Sánchez-Hidalgo J, Marchal T, Rufián S, López-Cillero P. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis. Liver Transpl 2009;15:37-48. [PMID: 19109846 DOI: 10.1002/lt.21566] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 5.3] [Reference Citation Analysis]
172 Wong TC, Fung JY, Chok KS, Cheung TT, Chan AC, Sharr WW, Dai WC, Chan SC, Lo CM. Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors. Liver Transpl 2016;22:226-36. [PMID: 26359934 DOI: 10.1002/lt.24335] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 7.0] [Reference Citation Analysis]
173 Taki-Eldin A, Zhou L, Xie HY, Zheng SS. Liver regeneration after liver transplantation. Eur Surg Res. 2012;48:139-153. [PMID: 22572792 DOI: 10.1159/000337865] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
174 Alwayn IP, Porte RJ. How to make steatotic livers suitable for transplantation. Liver Transpl 2007;13:480-2. [DOI: 10.1002/lt.21026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
175 de Graaf EL, Kench J, Dilworth P, Shackel NA, Strasser SI, Joseph D, Pleass H, Crawford M, McCaughan GW, Verran DJ. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index. J Gastroenterol Hepatol. 2012;27:540-546. [PMID: 21777274 DOI: 10.1111/j.1440-1746.2011.06844.x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 97] [Article Influence: 10.3] [Reference Citation Analysis]
176 Akoad M, Wagener M, Francis F, Ahmed J, Ulizio D, Cacciarelli T. Outcome of Imported Liver Allografts and Impact on Patient Access to Liver Transplantation. Transplantation Proceedings 2006;38:3564-6. [DOI: 10.1016/j.transproceed.2006.10.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
177 Borchert D, Glanemann M, Mogl M, Langrehr JM, Neuhaus P. Older liver graft transplantation, cholestasis and synthetic graft function. Transpl Int. 2005;18:709-715. [PMID: 15910298 DOI: 10.1111/j.1432-2277.2005.00128.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
178 Dahrenmöller C, Reding R. Understanding the effect of corticosteroid pretreatment in brain-dead organ donors: new mechanistic insights for improvement of organ quality in liver transplantation. Clin Sci (Lond) 2017;131:2377-9. [PMID: 28870982 DOI: 10.1042/CS20170178] [Reference Citation Analysis]